CARDIOMETABOLIC ADVERSE EFFECTS AND ITS PREDICTORS IN CHILDREN AND ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS DURING TREATMENT WITH QUETIAPINE-ER VERSUS ARIPIPRAZOLE: 12-WEEK RESULTS: FROM THE TEA TRIAL

Authors
Category Primary study
JournalSCHIZOPHRENIA BULLETIN
Year 2019
This article has no abstract
Epistemonikos ID: 0c305f786af4da2a3b9cc0e754c69b4e1cdade5c
First added on: Feb 11, 2025